• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular mechanisms for loss of contact inhibition in the cell motility of sarcoma and cancer invasion

Research Project

Project/Area Number 26670677
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Orthopaedic surgery
Research InstitutionResearch Institute, Osaka Medical Center for Cancer and Cardiovascular Disaeses

Principal Investigator

TAKAHASHI Katsuhito  地方独立行政法人大阪府立病院機構大阪府立成人病センター(研究所), その他部局等, その他 (40211338)

Co-Investigator(Kenkyū-buntansha) YAMAMURA Hisako  地方独立行政法人大阪府立病院機構大阪府立成人病センター(研究所), その他部局等, 研究員 (50342994)
Co-Investigator(Renkei-kenkyūsha) TOGUCHIDA Jyunya  京都大学, 生医科学研究所, 教授 (40273502)
Project Period (FY) 2014-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2014: ¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Keywordsかルポニン / 上皮間葉系転換 / カルポニン
Outline of Final Research Achievements

Cnn2 expression was examined in human breast cancer tissue microarrays and surgically resected tissues from human desmoplastic small round cell tumors (DSRCT) and malignant mesothelioma. Cnn2 was expressed in 30% of the 50 tissues samples of breast cancer, predominantly in the triple negative and high grade tumors. It was also highly expressed in all DSRCT and malignant mesothelioma tissues examined. 1D-Collision Assay system was established in mouse vascular smooth muscle and human clear cell sarcoma cells using the 1D motility assay chips and microscopic time lapse analyses. A 188bp-region containing CArG box upstream from transcrition start site in the mouse Cnn2 gene was identified as an essential promoter region for Cnn2 expression. The 239bp-region upstream from the transcription start site containig the above 188bp-region was most highy conserved in the human Cnn2 gene.

Report

(2 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • Research Products

    (6 results)

All 2014

All Presentation (6 results) (of which Invited: 2 results)

  • [Presentation] Clinical evaluation and treatment of leiomyosarcoma.2014

    • Author(s)
      K.Takahashi, H. Yamamura, Y. Koike, H. Narahara, Y. Ooyama, S. Toyooka, R. Hatae, Y. Ono, J. Yashima, S. Teraoka
    • Organizer
      The Japan-United States International Workshop for Sarcoma Research and Therapy
    • Place of Presentation
      Honolulu
    • Year and Date
      2014-12-04 – 2014-12-05
    • Related Report
      2014 Annual Research Report
    • Invited
  • [Presentation] Pazopanib for metastatic soft tissue sarcoma (STS) with or without denosumab.2014

    • Author(s)
      H. Narahara, K. Yasuda, K. Morita, N. Dan, R. Takeda, Y. Takeda, K. Yanagawa, J. Fukushima, H. Matsumoto, K. Matsunaga, S. Ueda, Y. Yasunaga, Y. Inui, S. Kawata, H. Yamamura, K. Takahashi.
    • Organizer
      The 39th Annual Meeting of The European Society of Medical Oncology (ESMO)
    • Place of Presentation
      Madrid
    • Year and Date
      2014-09-26 – 2014-09-30
    • Related Report
      2014 Annual Research Report
  • [Presentation] Efficient Formation and Characterization of 3D-Multicellular Tumor Spheroids of Soft Tissue Sarcomas.2014

    • Author(s)
      H. Yamamura, J. Yashima, S. Teraoka, Y. Ono, K. Kodama, Y. Tomita and K. Takahashi.
    • Organizer
      73rd Annual Meeting of The Japanese Cancer Association
    • Place of Presentation
      Yokohama
    • Year and Date
      2014-09-25 – 2014-09-27
    • Related Report
      2014 Annual Research Report
  • [Presentation] 稀少がん肉腫の新治療戦略;水平分業型治療連携とパゾパニブ血管新生阻害剤による分子標的治療2014

    • Author(s)
      高橋克仁
    • Organizer
      第52回日本癌治療学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2014-08-29
    • Related Report
      2014 Annual Research Report
    • Invited
  • [Presentation] High Throughput and Efficient Formation of 3D-Multicellular Tumor Spheroids of Soft Tissue Sarcomas; Implications for Silencing Mechanisms of Pathogenic Fusion Gene Expression.2014

    • Author(s)
      H. Yamamura, Y. Ono, J. Yashima, S. Teraoka and K. Takahashi.
    • Organizer
      52nd Annual Meeting of The Japan Society of Clinical Oncology
    • Place of Presentation
      Yokohama
    • Year and Date
      2014-08-28
    • Related Report
      2014 Annual Research Report
  • [Presentation] Systemic chemotherapy of pazopanib for advanced soft tissue sarcoma (STS) with or without denosumab.2014

    • Author(s)
      H. Narahatra, K. Yasuda, K. Morita, N. Dan, R. Takeda, Y. Takeda, K. Yanagawa, J. Fukushima, H. Matsumoto, K. Matsunaga, S. Ueda, Y. Yasunaga, Y. Inui, S. Kawata, H. Yamamura, K. Takahashi.
    • Organizer
      The 12th Annual Meeting of Japanese Society of Medical Oncology
    • Place of Presentation
      Fukuoka
    • Year and Date
      2014-07-17
    • Related Report
      2014 Annual Research Report

URL: 

Published: 2014-04-04   Modified: 2016-06-03  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi